- Poster presentations
- Open Access
Antimalarial drugs: unexpected evolutionary consequences
© Schneider et al; licensee BioMed Central Ltd. 2010
- Published: 20 October 2010
- Malaria Parasite
- Parasite Survival
- Rodent Malaria
For malaria parasites, exposure to drugs is now an integral, human-induced, part of their ecology that exerts substantial selective effects on their traits. Currently used drugs often do not eliminate transmission, which enables evolution of traits that are beneficial for parasites. The appearance and spread of resistance mutations that protect parasites through direct interactions with drug molecules are well documented and often assumed to underlie treatment failures. However, this is just one example of how parasites can minimise their vulnerability to drugs. Other parasite traits (e.g. growth rate, conversion rate, red blood cell preference) that parasites have evolved independently of drugs can also provide indirect protection from drugs. Both lab and field data suggest that such traits can influence parasite survival and transmission in drug treated malaria infections.
We used a rodent malaria model (Plasmodium chabaudi) to test if virulence can confer protection to parasites in drug-treated infections. Mice were infected with genetically similar virulent or avirulent genotypes (CWvir orCWavir), with or without an additional competing genotype (DK). Parasites were then exposed to drugs (control, pyrimethamine or artemisinin, across several doses and treatment regimes) and we compared parasite survival, production of gametocytes and, in a subset of infections, transmission to mosquitoes.
We show virulent parasites better survived treatment with pyrimethamine1 or artemisinin, and produce more gametocytes than genetically related avirulent parasites. The survival and gametocyte production benefits for the virulent parasites held fora range of drug doses, duration of treatment and for drugs with different modes of action.
Drug sensitivity can be virulence dependent, leading to a survival and transmission advantage for virulent parasites. If these results are general across parasite genotypes and species, this has consequences for the evolutionary trajectories of parasites resulting from continued population-wide exposure to drugs2. I will discuss how to overcome the challenge of translating our laboratory findings to natural infections in humans and how to integrate our epidemiological and evolutionary findings into a framework for malaria control.
- Schneider P, Chan BH, Reece SE, Read AF: Does the drug sensitivity of malaria parasites depend on their virulence?. Malaria Journal. 2008, 7: 257-10.1186/1475-2875-7-257.PubMed CentralView ArticlePubMedGoogle Scholar
- Stein WD, Sanchez CP, Lanzer M: Virulence and drug resistance in malaria parasites. Trends in Parasitology. 2009, 25: 441-443. 10.1016/j.pt.2009.07.003.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.